Need help finding instrument?
We will gladly assist you in making the right decision to achieve your business goals
HUMAN’s tumor marker reagents deliver reliable solutions for the quantification of key oncology biomarkers, including alpha-fetoprotein (AFP), cancer antigens CA 125, CA 15-3, CA 19-9, carcinoembryonic antigen (CEA), and prostate-specific antigens (PSA and fPSA). These assays support the diagnosis, prognosis, and treatment monitoring of various malignancies, including hepatocellular carcinoma, ovarian, breast, pancreatic, and prostate cancers. Calibrated to international standards such as WHO, these reagents ensure precise measurements and compatibility with advanced laboratory systems, enhancing the efficiency and accuracy of oncology diagnostics.
14 Items are shown
Quantitative determination of alpha-Fetoprotein
Quantitative determination of cancer antigen 125
Quantitative determination of cancer antigen 15-3
Quantitative determination of cancer antigen 19-9
Quantitative determination of carcinoembryonic antigen
Quantitative determination of free prostate specific antigen
Quantitative determination of total prostate specific antigen Remark: WHO Calibration
Quantitative determination of total prostate specific antigen
We will gladly assist you in making the right decision to achieve your business goals